High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorShanghai Zhongshan Hospital

About this trial

During sedated gastroscopy, the insertion of the fiberscope and gastric distension required to perform the examination may induce respiratory depression, airway obstruction, and decreased chest wall compliance. Patients with obesity, especially visceral fat, have poor lung and chest wall compliance, lower lung capacity and functional residual capacity, and an unbalanced ventilation-to-perfusion ratio. Thus, obese patients are at a high risk of hypoxemia.

Increasing evidence supports the use of High-flow nasal cannula (HFNC) oxygenation in obese patients during sedated gastrointestinal endoscopy. Obesity, especially visceral obesity, is an established risk factor associated with all-cause mortality. Body roundness index (BRI) is a newer anthropometric measure associated with identification of high-risk individuals. Owing to the limited evidence, we designed this unblinded randomized controlled trial to assess whether HFNC, compared to standard mask oxygenation, improves oxygenation at the end of the procedure (primary endpoint) in patients with visceral obesity.

Eligibility criteria

Qualifiers

ASA class ≤Ⅲ

Visceral obesity(body mass index≥28 and BRI ≥5.46)

Patients who will undergo sedated gastroscopy

Disqualifiers

Life-threatening heart disease or acute myocardial infarction within 6 weeks

Presence of pneumothorax or pulmonary bullae, pulmonary embolism, pulmonary oedema

Upper respiratory tract infection

Presence of tracheostomy

Trial design

Treatments tested in this trial

  • High Flow Nasal Cannula Oxygenation
  • Face Mask Oxygenation

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators